Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell.
These synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.
Stem cell therapies work by promoting endogenous repair; that is, they aid damaged tissue in repairing itself by secreting “paracrine factors,” including proteins and genetic materials.
While America continues to waste put its money into Embryonic Stem Cell research, a doctor in Iraq is actually treating patients with their own Adult Stem Cells. Dr. Abdul Majeed Alwan Hammadi is treating patients for free- and has so far treated 34 patients with stem cell therapy and treatment, mainly patients with Multiple […]
IntelliCell BioSciences filed its patent application with the US Patent office that will claim priority to its provisional US patent serial #61/427, 221 that was filed on December 27, 2010. The title of the patent application is Ultrasonic Cavitation Derived Stromal or Mesenchymal Vascular Extracts and Cells Derived Therefrom Obtained from Adipose Tissue and use Thereof. It covers the methods of manufacturing using ultrasonic cavitation to dissociate the fat cells and blood vessels contained within the adipose tissue, thereby obtaining multi-potent, mesenchymal or stromal vascular fractions for use in human subjects. These methods do not include the use of
After much hope and controversy, for the first time stem cells have proven to have the ability to cure blindness.
The news comes from a study on age-related macular degeneration (AMD) of the retina, the most common cause of blindness in individuals over the age of 50.
The Sunday Times reports that the treatment was developed by a group of British researchers, who say that in the next six to seven years the treatment will become a routine operation, which will not last more than an hour.
The treatment involves the replacement of a layer of degenerated cells with new cells created
Image via Wikipedia
The Missouri Roundtable for Life, a St. Louis area association led by conservative Ed Martin is organizing events to collect signatures for a November 2010 referendum.
The proposal, presented to the Secretary of State office, entitled “Amendment for the protection of taxpayer money”, asks to not use taxpayer money to fund abortion, human cloning, and other controversial research.
The group’s website, states that they are concerned with limiting or eliminating the effects of Amendment 2 passed in 2006 by a light majority, a law that protects research permitted by federal laws.